This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gauvrit, A. Articles by Gregoire, M. Search for Related Content PubMed PubMed Citation Articles by Gauvrit, A. Articles by Gregoire, M.

Measles Virus Induces Oncolysis of Mesothelioma Cells and Allows Dendritic Cells to Cross-Prime Tumor-Specific CD8 Response

¹ INSERM, U601, Cancerology Research Department, Nantes, France and ² Pasteur Institut, CNRS, URA3015, Viral Genomics and Vaccination Laboratory, Paris, France

Requests for reprints: Marc Gregoire, Institut de Biologie, Institut National de la Sante et de la Recherche Medicale, U601, 9 quai Moncousu, 44093 Nantes Cedex 01, France. Phone: 33-2-40-08-41-50; Fax: 33-2-40-08-40-82; E-mail: marc.gregoire{at}nantes.inserm.fr.

Key Words: Mesothelioma • Measles • Oncovirotherapy • Tumoral immunity • Dendritic cells • Cross-priming • Mesothelin

Despite conventional medical and surgical treatments, malignant pleural mesothelioma (MPM) remains incurable. Oncovirotherapy (i.e., the use of replication-competent virus for cancer treatment) is currently explored in clinical trials. In this study, we investigated the antineoplastic potential of a new oncolytic viral agent, a live-attenuated measles virus (MV) strain derived from the Edmonston vaccine lineage (Schwarz strain). We evaluated both oncolytic activity and immunoadjuvant properties of the MV vaccine strain on mesothelioma tumor cells. Infectivity, syncytium formation, and cytolytic activity of MV were studied on a panel of mesothelioma cells derived from pleural effusions of MPM patients. We observed that MV infected preferentially MPM cell lines in comparison with nontransformed mesothelial cells, leading to an efficient killing of a significant fraction of tumor cells. A cytoreductive activity was also evidenced through formation of multinuclear cellular aggregates (syncytia). The susceptibility of MPM cell lines to measles infection was assessed by the analysis of cell surface expression of the MV vaccine receptor (CD46). We also evaluated whether MV infection of mesothelioma cells could elicit an autologous antitumor immune response. We showed that MV Schwarz strain induced apoptotic cell death of infected mesothelioma cells, which were efficiently phagocytosed by dendritic cells (DC). Loading of DCs with MV-infected MPM cells induced DC spontaneous maturation, as evidenced by the increased expression of MHC and costimulatory molecules along with the production of proinflammatory cytokines. Priming of autologous T cells by DCs loaded with MV-infected MPM cells led to a significant proliferation of tumor-specific CD8 T cells. Altogether, these data strongly support the potential of oncolytic MV as an efficient therapeutic agent for mesothelioma cancer. [Cancer Res 2008;68(12):4882–92]

This article has been cited by other articles:

				S. Pillet and V. von Messling Canine Distemper Virus Selectively Inhibits Apoptosis Progression in Infected Immune Cells J. Virol., June 15, 2009; 83(12): 6279 - 6287. [Abstract] [Full Text] [PDF]